Science

AddToAny

Google+ Facebook Twitter Twitter

Autoimmune diseases revisited pt.1

Following articles on Addison’s, Crohn’s and Graves, this review describes some significant historical developments in our understanding of autoimmunity.

Autoimmune diseases develop when the autoreactive B lymphocytes produce autoantibodies and autoreactive T lymphocytes cause damage to the cells, tissues or organs that display specific target autoantigens to cause inflammation, cell abnormalities or cell destruction. In autoimmune diseases autoreactive lymphocytes expand polyclonally because critical control measures fail, so many different types of autoreactive lymphocytes are produced against a greater range of target antigens increasing their potential to cause more severe pathological damage.

Click here to read the full article

Image credit | Alamy

Related Articles

Medical Science Laboratory with Diverse Multi-Ethnic Team of Microbiology Scientists Have Meeting on Developing Drugs, Medicine, Doing Biotechnology Research-CREDIT_istock-1293772951

Equity, diversity and inclusion for all

Jemma Shead, a Senior Biomedical Scientist at Synnovis and IBMS EDI Working Group member, on how and why you should get involved with EDI.

adeno associated virus capsid-Image Credit | Science Photo Library - c0142837

Examining the medical mystery of child hepatitis outbreak

A study has shed light on an unexpected wave of severe acute hepatitis cases in 2022, amid the backdrop of the ongoing global COVID-19 pandemic.

clostridioides difficile bacteria-Image Credit | Science Photo Library - c0016337

Faecal microbiota transplant for C. diff

In the first comprehensive US evidence-based guideline on the use of faecal microbiota-based therapies for gastrointestinal disease, the American Gastroenterological Association recommends faecal microbiota transplant (FMT) for most patients with recurrent Clostridioides difficile (C. diff) infection.

pseudomonas aeruginosa bacteria Image-Credit | Science Photo Library - f0381226

Tackling priority pathogen with phages

A new study describes the use of phage therapy to eradicate multidrug-resistant Pseudomonas aeruginosa infections in vivo with important new implications for antibiotic resistance.

Top